Drugs / MVP005
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01622504 | Jun → Jul 2012 | acute opioid poisoning | Mitovie Pharma Ltd | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MVP005 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01622504 ↗ |
| Route | Intranasal | “2 mg single dose administered intranasally” NCT01622504 ↗ |